Skip to main content
SpringerLink
Log in
Book cover

Cancer Neurology in Clinical Practice pp 327–338Cite as

Neurologic Complications of Genitourinary Malignancies

  • Chapter

Abstract

Tumors of the genitourinary system (including the prostate, kidneys, bladder, and testicles) account for almost one-fourth of internal malignancies. Tumors specific to the female genitourinary tract are discussed in Chapter 27. Tumors of these organs are associated with disparate neurologic manifestations. For example, prostate cancer produces most of its neurologic morbidity through its propensity for bony metastasis, whereas renal cell carcinoma and testicular germ cell tumors frequently metastasize to brain parenchyma. These tumors additionally span a wide range of treatment responsiveness that impacts on neurologic as well as on overall prognosis. In this chapter, we will provide an overview of the neurologic complications associated with each of these tumors, emphasizing the syndromes commonly seen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15–36.

    Article  PubMed  CAS  Google Scholar 

  2. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57–60.

    Article  PubMed  CAS  Google Scholar 

  3. DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. Lippincott-Raven, Philadelphial, 1997.

    Google Scholar 

  4. Anonymous. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urology 1997; 79: 235–246.

    Article  Google Scholar 

  5. Bayley A, Milosevic M, Blend R, Loge J, Gospodarowicz M, Boxen I, et al. A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer 2001;92:303–310.

    Google Scholar 

  6. Maranzano E, Latini P, Beneventi S, et al. Comparison of two different radiotherapy schedules for spinal cord compression in prostate cancer. Tumori 1998; 84: 472–477.

    Google Scholar 

  7. Flynn DF, Shipley WU. Management of spinal cord compression secondary to metastatic prostatic carcinoma. Urolog Clin North Arne 1991; 18: 145–152.

    CAS  Google Scholar 

  8. Susuki K, Matsumoto S, Kitagawa N, Shinohara H, Hasegawa O, Kuroiwa Y. Epidural compression of the cauda equina caused by vertebral osteoblastic metastasis of prostatic carcinoma: resolution by hormonal therapy. J Neurol Neurosurg Psychiatry 2000; 68: 514–515.

    Article  PubMed  CAS  Google Scholar 

  9. Sasagawa I, Gotoh H, Miyabayashi H, Yamaguchi O, Shiraiwa Y. Hormonal treatment of symptomatic spinal cord compression in advanced prostatic cancer. Intl Urol Nephrol 1991; 23: 351–356.

    Article  CAS  Google Scholar 

  10. Gonzalez-Barcena D, Vadillo-Buenfil M, Cortez-Morales A, et al. Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord. Urology 1995; 45: 275–281.

    Article  PubMed  CAS  Google Scholar 

  11. Iacovou JW, Marks JC, Abrams PH, Gingell JC, Ball AJ. Cord compression and carcinoma of the prostate: is laminectomy justified? Br J Urol 1985; 57: 733–736.

    Article  PubMed  CAS  Google Scholar 

  12. Osborn JL, Getzenberg RH, Trump DL. Spinal cord compression in prostate cancer. J Neuro-Oncol 1995; 23: 135–147.

    Article  CAS  Google Scholar 

  13. Smith EM, Hampel N, Ruff RL, Bodner DR, Resnick MI. Spinal cord compression secondary to prostate carcinoma: treatment and prognosis. J Urol 1993; 149: 330–333.

    PubMed  CAS  Google Scholar 

  14. Flynn DF, Shipley WU. Management of spinal cord compression secondary to metastatic prostatic carcinoma. Urolog Clin North Am 1991; 18: 145–152.

    CAS  Google Scholar 

  15. Bloomfield DJ. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. J Clin Oncol 1998; 16: 1218–1225.

    PubMed  CAS  Google Scholar 

  16. Coleman RE, Purohit OP, Vinholes JJ, Zekri J. High dose pamidronate: clinical and biochemical effects in metastatic bone disease. Cancer 1997; 80: 1686–1690.

    Article  PubMed  CAS  Google Scholar 

  17. Rosen HN, Rosenblatt M. Pharmacology of bisphosphonates. In: Rose BD, ed. UpToDate, Wellesley, MA, 2000.

    Google Scholar 

  18. Rosenthal MA, Rosen D, Raghavan D, et al. Spinal cord compression in prostate cancer. A 10-year experience. Br J Urol 1992; 69: 530–533.

    Article  PubMed  CAS  Google Scholar 

  19. Huddart RA, Rajan B, Law M, Meyer L, Dearnaley DP. Spinal cord compression in prostate cancer: treatment outcome and prognostic factors. Radiother Oncol 1997; 44: 229–236.

    Article  PubMed  CAS  Google Scholar 

  20. Kuban DA, el-Mandi AM, Sigfred SV, Schellhammer PF, Babb TJ. Characteristics of spinal cord compression in adenocarcinoma of prostate. Urology 1986; 28: 364–369.

    Article  PubMed  CAS  Google Scholar 

  21. Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000; 54: 1222–1226.

    Article  PubMed  CAS  Google Scholar 

  22. Sakurai N, Koike Y, Hashizume Y, Takahashi A. Dural arteriovenous malformation and sinus thromboses in a patient with prostate cancer: an autopsy case. Int Med 1992; 31: 1032–1037.

    Article  CAS  Google Scholar 

  23. Taylor HG, Lefkowitz M, Skoog SJ, Miles BJ, McLeod DG, Coggin JT. Intracranial metastases in prostate cancer. Cancer 1984; 53: 2728–2730.

    Article  PubMed  CAS  Google Scholar 

  24. Castaldo JE, Bernat JL, Meier FA, Schned AR. Intracranial metastases due to prostatic carcinoma. Cancer 1983; 52: 1739–1747.

    Article  PubMed  CAS  Google Scholar 

  25. Sutton MA, Watkins HL, Green LK, Kadmon D. Intracranial metastases as the first manifestation of prostate cancer. Urology 1996; 48: 789–793.

    Article  PubMed  CAS  Google Scholar 

  26. Zachariah B, Casey L, Zachariah SB, Baekey P, Greenberg HM. Case report: brain metastasis from primary small cell carcinoma of the prostate. Am J Med Sci 1994; 308: 177–179.

    Article  PubMed  CAS  Google Scholar 

  27. Catane R, Kaufman J, West C, Merrin C, Tsukada Y, Murphy GP. Brain metastasis from prostatic carcinoma. Cancer 1976; 38: 2583 2587.

    Google Scholar 

  28. Kasabian NG, Previte SR, Kaloustian HD, Ganem EJ. Adenocarcinoma of the prostate presenting initially as an intracerebral tumor. Cancer 1992; 70: 2149–2151.

    Article  PubMed  CAS  Google Scholar 

  29. Zhang X, Tsukuda F, Yamamoto N, Takenaka I. Brain metastasis from prostate cancer: a case report. Intl J Urol 1997; 4: 519–521.

    Article  CAS  Google Scholar 

  30. Ransom DT, Dinapoli RP, Richardson RL. Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 1990; 65: 586–589.

    Article  PubMed  CAS  Google Scholar 

  31. Gupta SR, Zdonczyk DE, Rubino FA. Cranial neuropathy in systemic malignancy in a VA population. Neurol 1990; 40: 997–999.

    Article  CAS  Google Scholar 

  32. Seymore CH, Peeples WJ. Cranial nerve involvement with carcinoma of prostate. Urology 1988; 31: 211–213.

    Article  PubMed  CAS  Google Scholar 

  33. Barolat-Romana G, Maiman D, Dernbach P, Choi H. Prostate carcinoma presenting as intracranial hemorrhage. Case report. J Neurosurg 1984; 60: 414–416.

    Article  PubMed  CAS  Google Scholar 

  34. Minette SE, Kimmel DW. Subdural hematoma in patients with systemic cancer. Mayo Clin Proc 1989; 64: 637–642.

    Article  PubMed  CAS  Google Scholar 

  35. Schaller B, Merlo A, Kirsch E, et al. Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature. Br J Cancer 1998; 77: 2386–2389.

    Article  PubMed  CAS  Google Scholar 

  36. Aguilera NJ, Lopez DJ, Gil NE, Gil PA. [Neoplastic lumbosacral plexopathy and “hot foot”]. Neurologia 1993; 8: 271–273.

    Google Scholar 

  37. Rubin DI, Kimmel DW, Cascino TL. Outcome of peroneal neuropathies in patients with systemic malignant disease. Cancer 1998; 83: 1602–1606.

    Article  PubMed  CAS  Google Scholar 

  38. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine 1985; 64: 16–35.

    Article  PubMed  CAS  Google Scholar 

  39. Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994; 25: 1215–1218.

    Article  PubMed  CAS  Google Scholar 

  40. Chang DS, Hwang SL, Howng SL, Chai CY. Prostatic carcinoma with brain metastasis presenting as a tumor hemorrhage. KaoHsiung i Hsueh Ko Hsueh Tsa Chih [Kaohsiung J Med Sci] 1998; 14: 247–250.

    CAS  Google Scholar 

  41. Baloh RW, DeRossett SE, Cloughesy TF, et al. Novel brainstem syndrome associated with prostate carcinoma. Neurology 1993; 43: 2591–2596.

    Article  PubMed  CAS  Google Scholar 

  42. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992; 71: 59–72.

    Article  PubMed  CAS  Google Scholar 

  43. Posner JB. Neurologic Complications of Cancer. F.A. Davis Company, Philadelphia, 1995.

    Google Scholar 

  44. Greenlee JE, Jaeckle KA, Bashear HR, et al. Type II (Anti-Hu“) antibody in suspected paraneoplastic syndromes: association with conditions other than small-cell lung cancer and initial detection of antibody at very low titer [abstract]. Ann Neurol 1991; 30: 308.

    Google Scholar 

  45. Boninsegna C, Lovaste MG, Ferrari G. Carcinoma of the prostate and motor neuron disease. Italian J Neurolog Sci 1985; 6: 101–105.

    Article  CAS  Google Scholar 

  46. Agarawal SK, Birch BR, Abercrombie GF. Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association. Scand J Urol Nephrol 1995; 29: 351–353.

    Article  PubMed  CAS  Google Scholar 

  47. Tetu B, Ro JY, Ayala AG, Ordonez NG, Logothetis CJ, von Eschenbach AC. Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 1989; 33: 148–152.

    Article  PubMed  CAS  Google Scholar 

  48. Machtey I. Polymyositis associated with carcinoma of the prostate. J Am Geriatr Society 1970; 18: 250–255.

    CAS  Google Scholar 

  49. Ansai S, Koseki S, Takeda H, Kondo S, Yamakawa M. Dermatomyositis accompanied by prostatic cancer and elevated serum CA 19.9. Intl J Dermatol 1996; 35: 570–571.

    Article  CAS  Google Scholar 

  50. Park Y, Oster MW, Olarte MR. Prostatic cancer with an unusual presentation: polymyositis and mediastinal adenopathy. Cancer 1981; 48: 1262–1264.

    Article  PubMed  CAS  Google Scholar 

  51. Lafeuillade A, Quilichini R, Chiozza R, Pellegrino P, Thirkill CE. [Paraneoplastic retinopathy (CAR syndrome) revealing prostatic cancer]. Presse Med 22: 35–16.

    Google Scholar 

  52. Beard CJ, Lamb C, Buswell L, et al. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Intl J Radiat Oncol Biol Physics 1998; 41: 257–262.

    Article  CAS  Google Scholar 

  53. Vugrin D, Cvitkovic E, Posner J, Hajdu S, Golbey RB. Neurological complications of malignant germ cell tumors of testis: biology of brain metastases (I). Cancer 1979; 44: 2349–2353.

    Article  PubMed  CAS  Google Scholar 

  54. Williams SD, Einhorn LH. Brain metastases in disseminated germinal neoplasms: incidence and clinical course. Cancer 1979; 44: 1514–1516.

    Article  PubMed  CAS  Google Scholar 

  55. Bokemeyer C, Nowak P, Haupt A, et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997; 15: 1449–1454.

    PubMed  CAS  Google Scholar 

  56. Bredael JJ, Vugrin D, Whitmore WF, Jr. Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 1982; 50: 548–551.

    Article  PubMed  CAS  Google Scholar 

  57. Lester SG, Morphis JG, Hornback NB, Williams SD, Einhorn LH. Brain metastases and testicular tumors: need for aggressive therapy. J Clin Oncol 1984; 2: 1397–1403.

    PubMed  CAS  Google Scholar 

  58. Gerl A, Clemm C, Kohl P, Schalhorn A, Wilmanns W. Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancer. Clin Exp Metast 1994; 12: 226–230.

    Article  CAS  Google Scholar 

  59. Spears WT, Morphis JG, Lester SG, Williams SD, Einhorn LH. Brain metastases and testicular tumors: long-term survival. International J Radiat Oncol Biol Physics 22: 17–22.

    Google Scholar 

  60. Rustin GJ, Newlands ES, Bagshawe KD, Begent RH, Crawford SM. Successful management of metastatic and primary germ cell tumors in the brain. Cancer 1986; 57: 2108–2113.

    Article  PubMed  CAS  Google Scholar 

  61. Yamada M, Okeda R, Chen W, Nito H, Hatakeyama S, Tsukagoshi H. Cortical cerebellar degeneration with testicular neoplasm. Acta Neuropatholog 1985; 66: 170–172.

    Article  CAS  Google Scholar 

  62. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340: 1788–1795.

    Article  PubMed  CAS  Google Scholar 

  63. Dalmau J, Gultekin SH, Voltz R, et al. Mal, a novel neuron-and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999; 122: 27–39.

    Article  PubMed  Google Scholar 

  64. Mathews VP, Broome DR, Smith RR, Bognanno JR, Einhorn LH, Edwards MK. Neuroimaging of disseminated germ cell neoplasms. AJNR 1990; 11: 319–324.

    PubMed  CAS  Google Scholar 

  65. Mackey JR, Venner P. Seminoma with isolated central nervous system relapse, and salvage with craniospinal irradiation. Urology 1998; 51: 1043–1045.

    Article  PubMed  CAS  Google Scholar 

  66. Rouah E, Goodman JC, Harper RL. Acute subdural hematoma and metastatic seminoma. Neurology 1986; 36: 418–420.

    Article  PubMed  CAS  Google Scholar 

  67. Hitchins RN, Philip PA, Wignall B, et al. Bone disease in testicular and extragonadal germ cell tumours. Br J Cancer 1988; 58: 793–796.

    Article  PubMed  CAS  Google Scholar 

  68. Friedman HM, Sheetz S, Levine HL, Everett JR, Hong WK. Combination chemotherapy and radiation therapy. The medical management of epidural spinal cord compression from testicular cancer. Arch Int Med 1986; 146: 509–512.

    Article  CAS  Google Scholar 

  69. Horvath L, Bayfield M, Clifford A, Painter D, Clarke S. Unusual presentations of germ cell tumors: Case 1. Recurrent laryngeal nerve palsy in mediastinal seminoma. J Clin Oncol 2001; 19: 909–911.

    PubMed  CAS  Google Scholar 

  70. Jain KK, Bosl GJ, Bains MS, Whitmore WF, Golbey RB. The treatment of extragonadal seminoma. J Clin Oncol 1984; 2: 820–827.

    PubMed  CAS  Google Scholar 

  71. Hans S, Lindner DW, Webster JD. Brachial plexus neuropathy from metastatic testicular seminoma. Prolonged survival after surgery and radiation therapy. Urology 1985; 25: 398–400.

    Article  PubMed  CAS  Google Scholar 

  72. Kristensen O, Melgard B, Schiodt AV. Radiation myelopathy of the lumbo-sacral spinal cord. Acta Neurolog Scand 1977; 56: 217–222.

    Article  CAS  Google Scholar 

  73. Bowen J, Gregory R, Squier M, Donaghy M. The post-irradiation lower motor neuron syndrome neuronopathy or radiculopathy? Brain 1996; 119: 1429–1439.

    Article  PubMed  Google Scholar 

  74. West DA, Parra RO, Manepalli A, Bernardi RJ, Cummings JM. Development of a malignant peripheral nerve sheath tumor following treatment for testicular seminoma. Urology 1997; 50: 292–294.

    Article  PubMed  CAS  Google Scholar 

  75. Hansen SW, Helweg-Larsen S, Trojaborg W. Long-term neuro-toxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol 1989; 7: 1457–1461.

    PubMed  CAS  Google Scholar 

  76. Eeles R, Tait DM, Peckham MJ. Lhermitte’s sign as a complication of cisplatin-containing chemotherapy for testicular cancer. Cancer Treat Reports 1986; 70: 905–907.

    CAS  Google Scholar 

  77. Hall MC, Koch MO, Smith JA, Jr. Femoral neuropathy complicating urologie abdominopelvic procedures. Urology 1995; 45: 146–149.

    Article  PubMed  CAS  Google Scholar 

  78. Leibovitch I, Nash PA, Little JSJ, Foster RS, Donohue JP. Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer. J Urol 1996; 155: 947–951.

    Article  PubMed  CAS  Google Scholar 

  79. Whitmore WFJ, Batata MA, Ghoneim MA, Grabstald H, Unal A. Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 1977; 118: 184–187.

    PubMed  Google Scholar 

  80. Dhote R, Beuzeboc P, Thiounn N, et al. High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer. Euro Urol 1998; 33: 392–395.

    Article  CAS  Google Scholar 

  81. Sternberg CN, Yagoda A, Scher HI, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448–2458.

    Article  PubMed  CAS  Google Scholar 

  82. Rosenstein M, Wallner K, Scher H, Sternberg CN. Treatment of brain metastases from bladder cancer. J Urol 1993; 149: 480–483.

    PubMed  CAS  Google Scholar 

  83. Hust MH, Pfitzer P. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder. Acta Cytolog 1982; 26: 217–223.

    CAS  Google Scholar 

  84. Eng C, Cunningham D, Quade BJ, Schwamm L, Kantoff PW, Skarin AT. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer 1993; 72: 553–557.

    Article  PubMed  CAS  Google Scholar 

  85. Lowe BA, Mershon C, Mangalik A. Paraneoplastic neurological syndrome in transitional cell carcinoma of the bladder. J Urol 1992; 147: 462–464.

    PubMed  CAS  Google Scholar 

  86. Russ BW, English JC, King DH, Halbach DP. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder. Cutts 1999; 63: 73–76.

    CAS  Google Scholar 

  87. Mallon E, Osborne G, Dinneen M, RJ ML, Glaser M, Bunker CB. Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Exp Dermatol 1999; 24: 94–96.

    Article  PubMed  CAS  Google Scholar 

  88. Bouropoulos C, Kanellakopoulou KD, Zarakovitis IE, Melekos MD. Paraneoplastic polymyositis associated with transitional cell carcinoma of the bladder. J Urol 1997; 157: 950–951.

    Article  PubMed  CAS  Google Scholar 

  89. Orrell RW, James-Galton M, Stevens JM, Rossor MN. Cerebral achromatopsia as a presentation of Trousseau’s syndrome. Postgrad Med J 1995; 71: 44–46.

    Article  PubMed  CAS  Google Scholar 

  90. Fawcett DP, McBrien MP. Transitional cell carcinoma of the renal pelvis presenting with peripheral neuropathy. Br J Urol 1977; 49: 202.

    Article  PubMed  CAS  Google Scholar 

  91. Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Ann Neurol 1999; 45: 805–809.

    Article  PubMed  CAS  Google Scholar 

  92. Liskow A, Chang CH, DeSanctis P, Benson M, Fetell M, Housepian E. Epidural cord compression in association with genitourinary neoplasms. Cancer 1986; 58: 949–954.

    Article  PubMed  CAS  Google Scholar 

  93. Jaeckle KA, Young DF, Foley KM. The natural history of lumbosacral plexopathy in cancer. Neurology 1985; 35: 8–15.

    Article  PubMed  CAS  Google Scholar 

  94. Stevens MJ, Gonet YM. Malignant psoas syndrome: recognition of an oncologie entity. Australasian Radiol 1990; 34: 150–154.

    Article  CAS  Google Scholar 

  95. Rogers LR, Borkowski GP, Albers JW, Levin KH, Barohn RJ, Mitsumoto H. Obturator mononeuropathy caused by pelvic cancer: six cases. Neurology 1993; 43: 1489–1492.

    Article  PubMed  CAS  Google Scholar 

  96. Hall MC, Koch MO, Smith JA, Jr. Femoral neuropathy complicating urologic abdominopelvic procedures. Urology 1995; 45: 146–149.

    Article  PubMed  CAS  Google Scholar 

  97. Kaisary AV, Smith P. Spinal cord ischemia after ligation of both internal iliac arteries during radical cystoprostatectomy. Urology 1985; 25: 395–397.

    Article  PubMed  CAS  Google Scholar 

  98. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Clinical Oncology. Churchill Livingstone, New York, 2000.

    Google Scholar 

  99. Wronski M, Maor MH, Davis BJ, Sawaya R, Levin VA. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Intl J Radiat Oncol Biol Physics 37: 753–759.

    Google Scholar 

  100. Gay PC, Litchy WJ, Casein TL. Brain metastasis in hypernephroma. J Neuro-Oncol 1987; 5: 51–56.

    Article  CAS  Google Scholar 

  101. Weisberg LA. Hemorrhagic metastatic intracranial neoplasms: clinical-computed tomographic correlations. Comput Radiol 1985; 9: 105–114.

    Article  PubMed  CAS  Google Scholar 

  102. Postler E, Meyermann R. Brain metastasis in renal cell carcinoma: clinical data and neuropathological differential diagnoses. Anticancer Res 1999; 19: 1579–1581.

    PubMed  CAS  Google Scholar 

  103. Seaman EK, Ross S, SawczukIS. High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma. J Neuro-Oncol 1995; 23: 253–256.

    Article  CAS  Google Scholar 

  104. Marshall ME, Pearson T, Simpson W, Butler K, McRoberts W. Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma. Urology 1990; 36: 300–302.

    Article  PubMed  CAS  Google Scholar 

  105. Maor MH, Frias AE, Oswald MJ. Palliative radiotherapy for brain metastases in renal carcinoma. Cancer 1988; 62: 1912–1917.

    Article  PubMed  CAS  Google Scholar 

  106. Culine S, Bekradda M, Kramar A, Rey A, Escudier B, Droz JP. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer 1998; 83: 2548–2553.

    Article  PubMed  CAS  Google Scholar 

  107. Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 1996; 47: 187–193.

    Article  PubMed  CAS  Google Scholar 

  108. Dayes LA, Rouhe SA, Barnes RW. Excision of multiple intracranial metastatic hypernephroma. Report of a case with a 7-year survival. J Neurosurg 1977; 46: 533–535.

    Article  PubMed  CAS  Google Scholar 

  109. Vleeming R, Dabhoiwala NF, Bosch DA. Ten years survival after recurrent intracranial metastases from a renal cell carcinoma. Br J Neurosurg 1994; 8: 229–231.

    Article  PubMed  CAS  Google Scholar 

  110. Badalament RA, Gluck RW, Wong GY, et al. Surgical treatment of brain metastases from renal cell carcinoma. Urology 1990; 36: 112–117.

    Article  PubMed  CAS  Google Scholar 

  111. Wronski M, Arbit E, Russo P, Galicich JH. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 1996; 47: 187–193.

    Article  PubMed  CAS  Google Scholar 

  112. Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, CabillinEngenhart R. [Brain metastases in renal cell carcinoma. Results of treatment and prognosis]. Urologe–Ausgabe A 1997; 36: 117–125.

    Article  CAS  Google Scholar 

  113. Schoggl A, Kitz K, Ertl A, Dieckmann K, Saringer W, Koos WT. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochirurg 1998; 140: 549–555.

    Article  CAS  Google Scholar 

  114. Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 1998; 83: 344–353.

    Article  PubMed  CAS  Google Scholar 

  115. Ikushima H, Tokuuye K, Sumi M, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Intl J Radiat Oncol Biol Physics 2000; 48: 1389–1393.

    Article  CAS  Google Scholar 

  116. Breadmore R, House R, Gonzales M. Metastasis of renal cell carcinoma to a meningioma. Australasian Radiol 1994; 38: 144–143.

    Article  CAS  Google Scholar 

  117. Franke FE, Altmannsberger M, Schachenmayr W. Metastasis of renal carcinoma colliding with glioblastoma. Carcinoma to glioma: an event only rarely detected. Acta Neuropatholog 1990; 80: 448–452.

    Google Scholar 

  118. Killebrew K, Krigman M, Mahaley MSJ, Scatliff JH. Metastatic renal cell carcinoma mimicking a meningioma. Neurosurgery 1983; 13: 430–434.

    Article  PubMed  CAS  Google Scholar 

  119. Omland H, Fossa SD. Spontaneous regression of cerebral and pulmonary metastases in renal cell carcinoma. Scand J Urol Nephrol 1989; 23: 159–160.

    Article  PubMed  CAS  Google Scholar 

  120. Guthbjartsson T, Gislason T. Spontaneous regression of brain metastasis secondary to renal cell carcinoma. Scand J Urol Nephrol 1995; 29: 215–217.

    Article  PubMed  CAS  Google Scholar 

  121. Murata JI, Sawamura Y, Terasaka S, Saito H, Abe H. Complete response of a large brain metastasis of renal cell cancer to interferon-alpha: case report. Surg Neurol 1999; 51: 289–291.

    Article  PubMed  CAS  Google Scholar 

  122. Crino PB, Sater RA, Sperling M, Katsetos CD. Renal cell carcinomatous meningitis: pathologic and immunohistochemical features. Neurology 1995; 45: 189–191.

    Article  PubMed  CAS  Google Scholar 

  123. Reddy S, Hendrickson FR, Hoeksema J, Gelber R. The role of radiation therapy in the palliation of metastatic genitourinary tract carcinomas. A study of the Radiation Therapy Oncology Group. Cancer 1983; 52: 25–29.

    Article  PubMed  CAS  Google Scholar 

  124. Sundaresan N, Scher H, DiGiacinto GV, Yagoda A, Whitmore W, Choi IS. Surgical treatment of spinal cord compression in kidney cancer. J Clin Oncol 1986; 4: 1851–1856.

    PubMed  CAS  Google Scholar 

  125. Dun HR, Maier M, Pfahler M, Baur A, Refior HJ. Surgical treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthopaed Rel Res 1999; 283–290.

    Google Scholar 

  126. Sundaresan N, Choi IS, Hughes JE, Sachdev VP, Berenstein A. Treatment of spinal metastases from kidney cancer by presurgical embolization and resection. J Neurosurg 1990; 73: 548–554.

    Article  PubMed  CAS  Google Scholar 

  127. O’Reilly GV, Kleefield J, Klein LA, Blume HW, Dubuisson D, Cosgrove GR. Embolization of solitary spinal metastases from renal cell carcinoma: alternative therapy for spinal cord or nerve root compression. Surg Neurol 1989; 31: 268–271.

    Article  PubMed  Google Scholar 

  128. Kuether TA, Nesbit GM, Barnwell SL. Embolization as treatment for spinal cord compression from renal cell carcinoma: case report. Neurosurgery 1996; 39: 1260–1262.

    Article  PubMed  CAS  Google Scholar 

  129. Evans BK, Fagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology 1990; 40: 960–962.

    Article  PubMed  CAS  Google Scholar 

  130. Forman D, Rae-Grant AD, Matchett SC, Cowen JS. A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma. Chest 1999; 115: 899–901.

    Article  PubMed  CAS  Google Scholar 

  131. Wurzer H, Brandstatter G, Harnoncourt K, Kullnig P, Kleinert R. Paraneoplastic polymyositis associated with a renal carcinoma. J Int Med 1993; 234: 521–524.

    Article  CAS  Google Scholar 

Download references

Authors
  1. David Schiff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald L. Trump MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Y. Wen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Virginia Medical Center, Charlottesville, VA, USA

    David Schiff MD

  2. Center for Neuro-Oncology Dana-Farber Cancer Institute; and Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Patrick Y. Wen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schiff, D., Trump, D.L., Wen, P.Y. (2003). Neurologic Complications of Genitourinary Malignancies. In: Schiff, D., Wen, P.Y. (eds) Cancer Neurology in Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-317-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-317-0_22

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4703-4

  • Online ISBN: 978-1-59259-317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation